Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis.
Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?
Pharmaceutical Approval Update.
Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report.
Bilateral abducens nerve palsy in an infant case of fulminant acute disseminated encephalomyelitis: a case report.
Hemoglobins as new players in multiple sclerosis: metabolic and immune aspects.
Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients.
Acute Disseminated Encephalomyelitis.
Therapy satisfaction and adherence in patients with relapsing-remitting multiple sclerosis: the THEPA-MS survey.
Sex-based differences in autoimmune diseases.
The "butterfly diagram": A gait marker for neurological and cerebellar impairment in people with multiple sclerosis.
Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice.
Successive pregnancies in multiple sclerosis.
Gut microflora and multiple sclerosis.
Pain, cognition and quality of life associate with structural measures of brain volume loss in multiple sclerosis.
Publicly Available Data Provide Evidence against NR1H3 R415Q Causing Multiple Sclerosis.
Long-term effects of autoimmune CNS inflammation on adult hippocampal neurogenesis.
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis.
How long is the presymptomatic phase of multiple sclerosis?
Disability progression in aggressive multiple sclerosis.
Assessment of vitamin D status - a changing landscape.
Mutations in MYT1, encoding the myelin transcription factor 1, are a rare cause of OAVS.
Web-based interventions in multiple sclerosis: the potential of tele-rehabilitation.
Cortical Volume Loss and Neurologic Dysfunction in Multiple Sclerosis.
Sex differences and subclinical retinal injury in pediatric-onset MS.
Pages
« first
‹ previous
…
783
784
785
786
787
788
789
790
791
…
next ›
last »
